Ninth Circuit: FDA Can Regulate Stem Cell Clinic Procedure

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Ninth Circuit Says FDA Can Regulate Stem Cell Clinic Procedure, Reversing Lower Court’s Holding

Dennis Tosh

October 16, 2024 at 02:30 PM EST

Reversing an August 2022 district court decision, a federal appeals court had held that the FDA has the authority to regulate a stem cell treatment, concluding that stem cell mixtures injected into a treatment center’s patients were drugs regulated by the agency (United States v. California Stem Cell Treatment Center, Inc., 117 F.4th 1213 (9th Cir. 2024)). Physicians at a tre... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Ninth Circuit Says FDA Can Regulate Stem Cell Clinic Procedure, Reversing Lower Court’s Holding

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Ninth Circuit Says FDA Can Regulate Stem Cell Clinic Procedure, Reversing Lower Court’s Holding

My Research Folders

Related Articles

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT